Target intelligence / Profile preview

Gram-negative bacterial outer membrane lipopolysaccharide (LPS) phosphate group (LPS phosphate group)

Target
LPS phosphate group
Molecular classification
Bacterial cell wall component, Glycolipid component, Anionic surface group
01

Overview

Gram-negative bacterial outer membrane lipopolysaccharide (LPS) phosphate groups are essential anionic moieties located on the Lipid A and core oligosaccharide sections of the LPS molecule (Raetz & Whitfield, 2002). These groups play a vital role in bacterial survival by binding divalent cations, such as magnesium and calcium, which cross-link adjacent LPS molecules to stabilize the outer membrane and form a robust permeability barrier (Clifton et al., 2015). This barrier protects the bacteria from environmental stressors and many conventional antibiotics (Nikaido, 2003). In clinical medicine, these phosphate groups are the primary targets for polymyxin antibiotics, such as Polymyxin B and Colistin, which utilize electrostatic attraction to bind the membrane (Trimpa et al., 2015). The resulting displacement of stabilizing cations leads to membrane disruption, increased permeability, and bactericidal activity (Yu et al., 2015). However, bacteria can develop resistance by modifying these phosphate groups with moieties like phosphoethanolamine or 4-amino-4-deoxy-L-arabinose, reducing the net negative charge and drug binding affinity (Baron et al., 2016).

Other names
Lipid A phosphate groupLPS phosphateLipopolysaccharide anionic siteLPS-P
02

Mechanism of action

Polymyxins bind to the negatively charged phosphate groups of Lipid A in the bacterial outer membrane via electrostatic interactions. This binding displaces divalent cations (Mg2+ and Ca2+) that normally stabilize the lipopolysaccharide layer, resulting in increased membrane permeability, leakage of cytoplasmic contents, and bacterial cell death (StatPearls, 2023; Nature Reviews Microbiology, 2019).

03

Biological functions

Outer membrane stabilizationPermeability barrier maintenanceDivalent cation bindingStructural integrity
04

Disease associations

InfectionSepsisEndotoxemiaSeptic shock
05

Safety considerations

NephrotoxicityNeurotoxicityAntibiotic resistance via LPS modification
06

Interacting drugs

Polymyxin B

2 more in the full profile.

07

Biomarkers

LPS levelsmcr-1 gene expressionBacterial load

Beyond the preview

Go deeper on Gram-negative bacterial outer membrane lipopolysaccharide (LPS) phosphate group (LPS phosphate group).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial outer membrane lipopolysaccharide (LPS) phosphate group (LPS phosphate group).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call